C07C 275/42
Being further substituted by carboxyl groups
Official title: being further substituted by carboxyl groups
C07C275/42 (Being further substituted by carboxyl groups) appears on 361 US grants and 326 published applications in this corpus.
Search patents in C07C- Granted patents
- 361
- Published applications
- 326
- Assignees
- 217
- Inventors
- 1,288
- Latest grant
- 17 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 4 | 0 |
| 1978 | 10 | 0 |
| 1979 | 1 | 0 |
| 1980 | 1 | 0 |
| 1981 | 5 | 0 |
| 1982 | 3 | 0 |
| 1983 | 0 | 0 |
| 1984 | 4 | 0 |
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 3 | 0 |
| 1989 | 1 | 0 |
| 1990 | 3 | 0 |
| 1991 | 4 | 0 |
| 1992 | 2 | 0 |
| 1993 | 1 | 0 |
| 1994 | 5 | 0 |
| 1995 | 8 | 0 |
| 1996 | 5 | 0 |
| 1997 | 9 | 0 |
| 1998 | 7 | 0 |
| 1999 | 12 | 0 |
| 2000 | 10 | 0 |
| 2001 | 12 | 2 |
| 2002 | 22 | 17 |
| 2003 | 16 | 30 |
| 2004 | 15 | 31 |
| 2005 | 15 | 19 |
| 2006 | 10 | 21 |
| 2007 | 11 | 17 |
| 2008 | 12 | 18 |
| 2009 | 13 | 19 |
| 2010 | 10 | 14 |
| 2011 | 14 | 10 |
| 2012 | 11 | 12 |
| 2013 | 5 | 10 |
| 2014 | 15 | 13 |
| 2015 | 11 | 11 |
| 2016 | 9 | 14 |
| 2017 | 13 | 10 |
| 2018 | 10 | 8 |
| 2019 | 8 | 7 |
| 2020 | 6 | 11 |
| 2021 | 8 | 10 |
| 2022 | 7 | 8 |
| 2023 | 3 | 7 |
| 2024 | 2 | 4 |
| 2025 | 1 | 0 |
| 2026 | 2 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Epitope-based approach for allergy treatments and inhibitors for Crohn's disease17 Mar 2026US 12,576,123 B2Psomagen, Inc.
- 3,5-diaminobenzoic acid compound, and Pin1 inhibitor and therapeutic agent for inflammatory diseases using same10 Feb 2026US 12,545,643 B2Amenis Bioscience, Inc.
- Urea motif containing compounds and derivatives thereof as antibacterial drugs7 Jan 2025US 12,187,696 B2Technische Universität München
- Compositions and methods for the treatment of cancer24 Sep 2024US 12,098,117 B2Duke University
- Inhibitor of indoleamine-2,3-dioxygenase (IDO)30 Apr 2024US 11,969,425 B2Inventisbio Co., Ltd.
- Memantyl urea derivative, preparation method thereof, and use thereof in preparation of drug for treating soluble epoxide hydrolase-mediated disease6 Aug 2026US 2026/0224548 A1Guangdong Hongshanhu Pharmaceutical Co., Ltd.
- Covalent, chemogenetic activators for k2p potassium channels and uses thereof9 Apr 2026US 2026/0098008 A1The Regents of the University of California
- Neurotrophic Receptor Tyrosine Kinase (NTRK) Inhibitors and Methods Using Same19 Feb 2026US 2026/0049077 A1
- Compositions and methods for the treatment of cancer12 Dec 2024US 2024/0409504 A1Duke University
- Novel amino acid derivatives5 Dec 2024US 2024/0400499 A1PeptiDream Inc.
Most cited
By later US patents
- Inhibitors of IMPDH enzyme190US 5,807,876 AVertex Pharmaceuticals Incorporated · 1998
- Inhibitors of IMPDH enzyme127US 6,054,472 AVertex Pharmaceuticals Incorporated · 2000
- Benzamidine derivatives and their use as anti-coagulants92US 5,691,364 ABerlex Laboratories, Inc. · 1997
- IL-8 receptor antagonists92US 5,886,044 ASmithKline Beecham Corporation · 1999
- Bifunctional chelating agents91US 5,057,302 AAbbott Laboratories · 1991